Product

Company

NCT04425707·1 site·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Ministry of Health and Population, Egypt

the study will compare the effect of ivermectin in comaprison and addition to the standard mode of care for the COVID 19 patients

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

Asymptomatic mild cases and moderate cases proven to be infected by COVID 19 by viral RNA swap

Contraindications for the drug: hypersensitivity.
Any medications with possible drug interactions.
Severe cases.
Any malignant condition.
Pregnant females.
Breast feeding females.
Any patient on the following medications: Erdafitinib- Lasmiditan- Quinidine due to potential severe drug interaction.

The record

StatusUnknown

PhaseNo phase

Taking part100

StartedJun 2020

UpdatedJun 11, 2020

Conditions

Where1

Clareo Health | Ivermectin In Treatment of COVID 19 Patients